Genetically determined adverse drug reactions involving metabolismLENNARD, M. S.Drug safety. 1993, Vol 9, Num 1, pp 60-77, issn 0114-5916Article

Quantitative analysis of metoprolol and three of its metabolites in urine and liver microsomes by high-performance liquid chromatographyLENNARD, M. S.Journal of chromatography. 1985, Vol 342, Num 1, pp 199-205, issn 0021-9673Article

The polymorphic oxidation of beta-adrenoceptor antagonistsLENNARD, M. S.Pharmacology & therapeutics (Oxford). 1989, Vol 41, Num 3, pp 461-477, issn 0163-7258Article

Quantitative analysis of amitriptyline and nortriptyline in human plasma and liver microsomal preparations by high-performance liquid chromatographyGHAHRAMANI, P; LENNARD, M. S.Journal of chromatography. Biomedical applications. 1996, Vol 685, Num 2, pp 307-313, issn 0378-4347Article

Timolol determination in plasma and urine by high-performance liquid chromatography with ultraviolet detectionLENNARD, M. S; PARKIN, S.Journal of chromatography. 1985, Vol 338, Num 1, pp 249-252, issn 0021-9673Article

Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6LIN, L. Y; DI STEFANO, E. W; SCHMITZ, D. A et al.Drug metabolism and disposition. 1997, Vol 25, Num 9, pp 1059-1064, issn 0090-9556Article

An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat : relevance to its use as a model of the CYP2D6 poor metaboliser phenotypeBARHAM, H. M; LENNARD, M. S; TUCKER, G. T et al.Biochemical pharmacology. 1994, Vol 47, Num 8, pp 1295-1307, issn 0006-2952Article

Inhibition of metroprolol metabolism by chloroquine and other antimalarial drugsLANCASTER, D. L; ADIO, R. A; TAI, K. K et al.Journal of pharmacy and pharmacology. 1990, Vol 42, Num 4, pp 267-271, issn 0022-3573, 5 p.Article

Stereoselective metabolism of metoprolol in Caucasians and Nigerians ― relationship to debrisoquine oxidation phenotypeLENNARD, M. S; TUCKER, G. T; WOODS, H. F et al.British journal of clinical pharmacology. 1989, Vol 27, Num 5, pp 613-616, issn 0306-5251Article

Enantiomer specific pharmacokineticsTUCKER, G. T; LENNARD, M. S.Pharmacology & therapeutics (Oxford). 1989, Vol 45, Num 3, pp 309-329, issn 0163-7258Article

Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolitesCHING, M. S; BLAKE, C. L; GHABRIAL, H et al.Biochemical pharmacology. 1995, Vol 50, Num 6, pp 833-837, issn 0006-2952Article

Characterization of metronidazole metabolism by human liver microsomesLOFT, S; OTTON, S. V; LENNARD, M. S et al.Biochemical pharmacology. 1991, Vol 41, Num 8, pp 1127-1134, issn 0006-2952, 8 p.Article

Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjectsLEWIS, R. V; RAMSAY, L. E; JACKSON, P. R et al.British journal of clinical pharmacology. 1991, Vol 31, Num 4, pp 391-398, issn 0306-5251, 8 p.Article

Histamine inhibition of mixed function oxidase activity in rat and human liver microsomes and in the isolated perfused rat liverMORRIS, C. Q; TUCKER, G. T; CREWE, H. K et al.Biochemical pharmacology. 1989, Vol 38, Num 16, pp 2639-2644, issn 0006-2952Article

Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in manBAX, N. D. S; JONES, R. W; LENNARD, M. S et al.British journal of clinical pharmacology. 1985, Vol 19, Num 5, pp 593-596, issn 0306-5251Article

Comparison of two-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patientsSILAS, J. H; FREESTONE, S; LENNARD, M. S et al.British journal of clinical pharmacology. 1985, Vol 20, Num 4, pp 387-391, issn 0306-5251Article

Metoprolol metabolism and debrisoquine oxidation polymorphism―population and family studiesMCGOURTY, J. C; SILAS, J. H; LENNARD, M. S et al.British journal of clinical pharmacology. 1985, Vol 20, Num 6, pp 555-566, issn 0306-5251Article

Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studiesDAVIES, S. J. C; WESTIN, A. A; CASTBERG, I et al.Acta psychiatrica scandinavica. 2010, Vol 122, Num 6, pp 444-453, issn 0001-690X, 10 p.Article

Determination by liquid chromatography-mass spectrometry of clomiphene isomers in the plasma of patients undergoing treatment for the induction of ovulationCREWE, H. K; GHOBADI, C; GREGORY, A et al.Journal of chromatography. B. 2007, Vol 847, Num 2, pp 296-299, issn 1570-0232, 4 p.Article

Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres : a multicentre auditWILCOCK, A; THOMAS, J; FRISBY, J et al.British journal of clinical pharmacology. 2005, Vol 60, Num 3, pp 326-329, issn 0306-5251, 4 p.Article

Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamineHEYDARI, A; ROWLAND YEO, K; LENNARD, M. S et al.Drug metabolism and disposition. 2004, Vol 32, Num 11, pp 1213-1217, issn 0090-9556, 5 p.Article

A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatmentSHIRAN, M. R; CHOWDRY, J; ROSTAMI-HODJEGAN, A et al.British journal of clinical pharmacology. 2003, Vol 56, Num 2, pp 220-224, issn 0306-5251, 5 p.Article

Parkinson's disease and CYPIA2 activityFORSYTH, J. T; GRÜNEWALD, R. A; ROSTAMI-HODJEGAN, A et al.British journal of clinical pharmacology. 2000, Vol 50, Num 4, pp 303-309, issn 0306-5251Article

Halofantrine and chloroquine inhibit CYP2D6 activity in healthy ZambiansSIMOOYA, O. O; SIJUMBIL, G; LENNARD, M. S et al.British journal of clinical pharmacology. 1998, Vol 45, Num 3, pp 315-317, issn 0306-5251Article

Cytochromes P450 mediating the N-demethylation of amitriptylineGHAHRAMANI, P; ELLIS, S. W; LENNARD, M. S et al.British journal of clinical pharmacology. 1997, Vol 43, Num 2, pp 137-144, issn 0306-5251Conference Paper